AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 163 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $223 | -12.5% | 9 | 0.0% | 0.00% | – |
| Q2 2023 | $255 | +23.2% | 9 | 0.0% | 0.00% | – |
| Q1 2023 | $207 | -18.2% | 9 | 0.0% | 0.00% | – |
| Q4 2022 | $253 | – | 9 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 9 | -50.0% | 0.00% | – |
| Q1 2021 | $930,000 | – | 18 | +100.0% | 0.00% | – |
| Q4 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 9 | -99.0% | 0.00% | -100.0% |
| Q4 2019 | $43,000 | +22.9% | 909 | -18.0% | 0.00% | 0.0% |
| Q3 2019 | $35,000 | +250.0% | 1,109 | +430.6% | 0.00% | – |
| Q2 2019 | $10,000 | +900.0% | 209 | +2222.2% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 9 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |